Endpoints News

Endpoints News

Regeneron drug also gets agency nod		Read in browser

Thank you for reading, dupa dupackia!

basic

UPGRADE

M T W Thu F

20 August, 2026

Twenty new honorees join the 140-plus women Endpoints News has recognized for reshaping biopharma. How did they get there, and what's changed? Join us for exclusive interviews, in-depth profiles and a frank look at gender representation in the industry today. Register now.

news

Ultragenyx's gene therapy gets FDA OK for glycogen storage disorder

FDA approves Regeneron’s drug for ultra-rare disease that turns tissue to bone

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

•

Merck, Moderna declare Phase 3 success for personalized mRNA cancer vaccine

Aug 27

12:00 pm ET

Same molecule, different paths: Where value goes in cross-border dealmaking in a new era

sponsored by PharmCube

Sep 03

11:00 am ET

How leading pharma organizations are putting AI agents to work

sponsored by Medable

One night, one room: the founders, scientists and investors behind the Endpoints 11, together in Boston this September. Reserve your spot now and save with the early bird rate.

ENDPOINTS PHARMA

Who’s Heidi? Trump's new FDA pick has been critical of vaccine requirements, abortion pills

The most interesting takeaway from Anthropic’s design study has nothing to do with proteins

Federal appeals court revives part of Teva's IRA case as Austedo price cuts loom

in case you missed it

1.

Amylin design debate heats up as Lilly's crucial mid-stage weight loss data near

2.

Bristol Myers' China partner says bispecific ADC clears fourth cancer trial, this time in NSCLC

3.

News Briefing

Amgen cans its TScan partnership; Amylyx reveals $350M offering

4.

Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T

5.

Blood clot discovery upends consensus about how wounds heal

6.

How do people live beyond 110? Abundance of cancer-killing cells might be key

Reynald Castaneda

.

We're keeping a close eye on the XBI to see whether the record high of $174.79, set in February 2021, will be broken in the near future. Stay tuned.

.

Reynald Castaneda

Deputy Editor, Endpoints News

2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com